Salumag, Geraldine C.

HRN: 22-93-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/21/2023
04/27/2023
IV
500mg
TID
S/P LTCS
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: